Published online before print June 26, 2006, doi: 10.1161/CIRCULATIONAHA.105.610303
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;114:11-17.)
© 2006 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing
Meta-Analysis of Randomized Trials, Using Individual Patient Data
From the Population Health Research Institute (J.S.H., S.Y., S.J.C.), McMaster University, Hamilton, Canada; the Department of Cardiovascular Sciences (W.D.T., J.D.S.), University of Leicester, England; Mount Sinai Medical Center (G.A.L.), Miami Beach, Fla; Aarhus University Hospital (H.R.A.), Skejby Sygehus, Denmark; University of Toronto (K.E.T.), Toronto, Canada; Medical College of Virginia (K.A.E.), Richmond; Duke University (K.L.L.), Durham, NC; Nottingham Clinical Research Group (A.M.S.), Nottingham, England; National Heart, Lung, and Blood Institute (E.B.S.), Bethesda, Md; University of California (L.G.), San Francisco; Henderson Research Centre (R.S.R.), McMaster University, Hamilton, Canada; and St. George’s University of London (A.J.C.), London, England.
Correspondence to Jeff Healey, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada, L8L 2X2. E-mail healeyj{at}hhsc.ca
Received December 29, 2005; revision received March 30, 2006; accepted April 24, 2006.
Background— Several randomized trials have compared atrial-based (dual-chamber or atrial) pacing with ventricular pacing in patients with bradycardia. No trial has shown a mortality reduction, and only 1 small trial suggested a reduction in stroke. The goal of this review was to determine whether atrial-based pacing prevents major cardiovascular events.
Methods and Results— A systematic review was performed of publications since 1980. For inclusion, trials had to compare an atrial-based with a ventricular-based pacing mode; use a randomized, controlled, parallel design; and have data on mortality, stroke, heart failure, or atrial fibrillation. Individual patient data were obtained from 5 of the 8 identified studies, representing 95% of patients in the 8 trials, and a total of 35 000 patient-years of follow-up. There was no significant heterogeneity among the results of the individual trials. There was no significant reduction in mortality (hazard ratio [HR], 0.95; 95% confidence interval [CI], 0.87 to 1.03; P=0.19) or heart failure (HR, 0.89; 95% CI, 0.77 to 1.03; P=0.15) with atrial-based pacing. There was a significant reduction in atrial fibrillation (HR, 0.80; 95% CI, 0.72 to 0.89; P=0.00003) and a reduction in stroke that was of borderline significance (HR, 0.81; 95% CI, 0.67 to 0.99; P=0.035). There was no convincing evidence that any patient subgroup received special benefit from atrial-based pacing.
Conclusions— Compared with ventricular pacing, the use of atrial-based pacing does not improve survival or reduce heart failure or cardiovascular death. However, atrial-based pacing reduces the incidence of atrial fibrillation and may modestly reduce stroke.
CLINICAL PERSPECTIVE
Related Article:
-
Issue Highlights
Circulation 2006 114: 1.[Full Text]
This article has been cited by other articles:
 |
|
 |
|
  C. M. Fored, F. Granath, F. Gadler, P. Blomqvist, J. Rynder, C. Linde, A. Ekbom, and M. Rosenqvist Atrial vs. dual-chamber cardiac pacing in sinus node disease: a register-based cohort study Europace, July 1, 2008; 10(7): 825 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62. [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation, May 27, 2008; 117(21): e350 - e408. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Gillis, M. Morck, D. V. Exner, A. Soo, M. Sarah Rose, R. S. Sheldon, H. J. Duff, K. M. Kavanagh, L. Brent Mitchell, and D. George Wyse Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation Eur. Heart J., May 13, 2008; (2008) ehn192v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E.W. Hemels, J. H. Ruiter, G. P. Molhoek, N. J.G.M. Veeger, A. C.P. Wiesfeld, A. V. Ranchor, M. van Trigt, A. Pilmeyer, I. C. Van Gelder, and for The Features in AT500TM study; Chances for pat Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study Europace, March 1, 2008; 10(3): 306 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-P. Lau, H.-F. Tse, A. J. Camm, and S. S. Barold Evolution of pacing for bradycardias: sensors Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I11 - I22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. F. Tops, M. S. Suffoletto, G. B. Bleeker, E. Boersma, E. E. van der Wall, J. Gorcsan III, M. J. Schalij, and J. J. Bax Speckle-Tracking Radial Strain Reveals Left Ventricular Dyssynchrony in Patients With Permanent Right Ventricular Pacing J. Am. Coll. Cardiol., September 18, 2007; 50(12): 1180 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. O. Sweeney, A. J. Bank, E. Nsah, M. Koullick, Q. C. Zeng, D. Hettrick, T. Sheldon, G. A. Lamas, and the Search AV Extension and Managed Ventricular Pa Minimizing Ventricular Pacing to Reduce Atrial Fibrillation in Sinus-Node Disease N. Engl. J. Med., September 6, 2007; 357(10): 1000 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lewicka-Nowak, A. Kutarski, A. Dabrowska-Kugacka, P. Rucinski, P. Zagozdzon, and G. Raczak A novel method of multisite atrial pacing, incorporating Bachmann's bundle area and coronary sinus ostium, for electrical atrial resynchronization in patients with recurrent atrial fibrillation Europace, September 1, 2007; 9(9): 805 - 811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Schoenfeld Contemporary Pacemaker and Defibrillator Device Therapy: Challenges Confronting the General Cardiologist Circulation, February 6, 2007; 115(5): 638 - 653. [Full Text] [PDF]
|
|
|
|
 |
|
 Atrial-Based vs. Ventricular Pacing: A Meta-Analysis Journal Watch Cardiology, July 26, 2006; 2006(726): 1 - 1. [Full Text]
|
|
|
|
 |
|
 Minerva BMJ, July 15, 2006; 333(7559): 156 - 156. [Full Text] [PDF]
|
|
|
|
|
|
H.-F. Tse and C.-P. Lau Clinical Trials for Cardiac Pacing in Bradycardia: The End or the Beginning? Circulation, July 4, 2006; 114(1): 3 - 5. [Full Text] [PDF]
|
|